鉴定心脏性休克的生物标志物驱动子类型:对潜在队列和随机对照试验的分析
Sabri Soussi1,2, Tuukka Tarvasmäki3, Antoine Kimmoun4,5,6
1Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada.
EClinicalMedicine
|January 13, 2025
概括
使用生物标志物识别心脏性休克 (CS) 亚表型,可以改善风险分层. 炎症性和心脏病性CS亚型显示较高的死亡率,独立于休克阶段.
科学领域:
- 心脏病学 心脏病学
- 密集护理医学 密集护理医学
- 生物标志物发现发现
背景情况:
- 心脏性休克 (CS) 呈现出异质的临床挑战,使预后和治疗反应预测复杂化.
- 识别不同的CS生物/分子亚表型对于了解患者的病历至关重要.
- 冲击CO-OP研究 (NCT06376318) 旨在定义CS亚表型及其对治疗效果异质性的影响.
研究的目的:
- 识别和表征心脏性休克的不同生物/分子亚现型.
- 评估这些亚现象与患者的结果,特别是28天死亡率的关联.
- 在随机对照试验中探索在已识别的CS亚表型中治疗效果的异质性.
主要方法:
- 来自两个潜在队列 (CardShock,N=205;FROG-ICU,N=228) 的血生物标记数据的无监督聚类,以定义CS亚表型.
- 开发了一种简化分类器,用于在三个独立的随机对照试验 (RCT) 中分配子类型.
- 分析28天死亡率作为主要结果,并评估治疗效果异质性.
主要成果:
- 确定了四种不同的生物标志物驱动的CS亚表型 ("适应性"",非炎症"",心脏病"",炎症").
- "炎症"和"心脏病"亚表型与28天死亡率显著增加有关.
- 亚现象类型分类改善了风险分层,超越了传统因素,如SCAI冲击阶段 (哈雷尔C指数增加了4-6%).
结论:
- 生物标志物驱动的亚型揭示了具有不同死亡风险的独特心脏性休克特征.
- "炎症性"和"心脏病"亚表型是预后不良的关键指标,独立于SCAI冲击阶段.
- 识别的亚现型在独立的临床试验中表现出一致的生物学和结果特征.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
117
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
117